Main Menu
  • Our laboratory

    WHO ARE WE?

    CEVIDRA, a pharmaceutical establishment serving healthcare professionals.

    Learn more

    OUR VALUES

    The CEVIDRA Laboratory dedicates itself daily to improving the health and well-being of people suffering ...

    Learn more

    OUR ENGAGEMENTS

    Cevidra strives to meet the needs of its partners and consumers with reliable and quality products.

    Learn more

  • Our services

    IMPORT / EXPORT

    Effective and timely distribution of medicines and small and large medical supplies.

    Learn more

    DEPOSITARY / OPERATOR

    Permitted to store drugs, products, objects or items that the company does not own for distribution.

    Learn more

    REGULATORY AFFAIRS

    Thank to our quaified staff, the Laboratoire Cevidra advises and assists companies.

    Learn more

    PHARMACOVIGILANCE / MATERIOVIGILANCE

    To ensure quality and safety in the supply chain, we apply the standards of good distribution practice.

    Learn more

  • Our medications

    MEDICATION UNDER ATUc

    The drugs that the CEVIDRA laboratory markets are new treatments, curative or palliative, in therapeutic niches.

    Learn more

    MEDICATION UNDER ATUCn

    When the drug under ATU shows an efficacy established by the ANSM, CEVIDRA laboratory still registers under the control of ANSM the drug in ATU of Cohorte then in MA.

    Learn more

    AMM medications

    The Laboratoire CEVIDRA ensures, in consultation with the drug manufacturer, the registration and reimbursement processes with the competent authorities.

    Learn more

  • Medical devices

    BREATHING

    nasanita

    NASANITA® is a dilator to improve nasal breathing. Learn more

    ANTI-SNORING

    ANTI-RONFLEMENT

    NOZOVENT® : Find the right product for your type of snoring and find a peaceful sleep. Learn more

    DRY OR IRRITATED NOSE

    nozoil

    NOZOIL® : A nasal spray based on natural sesame oil that hydrates, decongests and soothes for all smoothness. Learn more

    NOSE HYGIENE

    Rhinicur

    NASAL SHOWER RHINICUR®  : A simple and easy way to wash your nose. Learn more

    NASAL SPRAY AND DROPS RHINICUR® : A natural care for babies and adults. Learn more

    COMPRESSION

    FOXEASYSOCKS

    FOX EASY SOCKS® : Easy to put on and remove socks and stockings. Learn more

  • Telemedicine, tele-expertise and remote diagnostics solutions

    DERMATOSCOPE WITH LED AND UV LIGHT

    DERMATOSCOPE

    Dermatoscope UV MIC-FI WiFi is a portable numerical dermatoscope with Wi-Fi transmission, white light and UV.  Learn more

    POLARIZING FILTER DERMATOSCOPE

    DERMATOSCOPE

    The polarizing filter dermatoscope is a numerical microscope with a Wi-Fi transmission. Learn More 

    NUMERICAL CAMERA

    Camera numerique

    The numerical camera MIC-FI WIFI is a WI-FI camera for instruments and devices with a C mount Learn more

    OTOSCOPE

    Otoscope

    Otoscope MIC-FI wifi is a numerical otoscope with Wi-Fi transmission.  Learn more

  • CONTACT US

NOS MEDICAMENTS

The CEVIDRA Laboratory works with innovative pharmaceutical laboratories based in France, Europe, North America or Australia and provides medicines to more than 800 healthcare institutions to treat, prevent or diagnose serious or rare diseases for which There is still no appropriate treatment benefiting from a marketing authorization in France.

The drugs that the CEVIDRA Laboratory markets are new treatments, curative or palliative, in therapeutic niches. These medications are often indispensable for the patient. When the new molecules or new dosage forms are available in marketing authorization or show an efficacy, from the Phase II or Phase III clinical study for the best molecules, the CEVIDRA Laboratory imports and Commercializes the medicinal product with the authorization of ANSM (the National Agency for the Safety of Medicines and Health Products). These drugs are often available in other countries in Europe through programs called "Named Patient Medicine", "Early Access Program" or "Compassionate Use".

Today, the CEVIDRA Laboratory is involved in the following therapeutic areas :

  • Cardiology
  • Infectious Diseases / parasitology
  • Neurology
  • Metabolism
  • pneumonology
  • Urology / Nephrology

Laboratoire CEVIDRA for Physicians, Hospital Pharmacists and Patients

The CEVIDRA Laboratory provides hospitals, doctors and pharmacists, and their patients with medicines that have not been approved by the National Agency for the Safety of Medicines and Health Products (ANSM).
These medicines are evaluated scientifically and technically for their quality, efficiency and safety of use. These medicines are only available in hospitals and in the framework of registered ATUs (Temporary Use Authorizations), cohort ATUs or authorization to import in exceptional cases in the event of a stock-out.

The CEVIDRA laboratory provides physicians and hospital pharmacists with information on new molecules or new galenic forms available. These new molecules are developed and produced in France, Europe or elsewhere in the world by pharmaceutical laboratories specialized in research on rare diseases.

Our pharmaceutical know-how with hospitals

In the framework of simple consultations, open or restricted invitations to tender, negotiated or adapted procedures, the laboratory cell of the CEVIDRA Laboratory is able to respond to requests from healthcare establishments, hospitals and clinics and to provide:

  • A wide range of medicines
  • Best rates for the majority of ATU drugs from Europe, America or Australia
  • A quick response to requests for information from the medical profession
  • A supply as soon as possible







TEMPORARY AUTHORIZATION FOR USE (ATUn)

The Temporary Use Exemption (ATUn) is the French equivalent of "Named Patient Medicine" or "Early Access Program".

These medicines which do not yet have a marketing authorization in France are imported with an ATU (Temporary Use Authorization) status under the control of ANSM. The CEVIDRA Laboratory distributes them under the status of Temporary Authorization of Nominative Use or ATUn. The CEVIDRA Laboratory does not have the right to communicate on these medicines, but doctors and pharmacists can find the information on the ANSM (National Agency for the Safety of Medicines and Health Products) website: specialties allowed in the framework Of nominative ATUs.

 

 




TEMPORARY AUTHORIZATION FOR THE USE OF COHORT (ATUc)

The Temporary Cohort Use Authorization (ATUc) is the French equivalent of "Compassionate Use" or "Early Access Program".

When the ATUn drug demonstrates efficacy established by ANSM or when a new molecule is available and no suitable treatment exists, the CEVIDRA Laboratory records, under the control and validation of ANSM, the Medication in ATUc (Temporary Cohort Use Authorization).
Within the framework of a cohort ATU, the CEVIDRA Laboratory establishes Therapeutic Use and Information Collection Protocols (PUT) to organize the provision of medicines to patients and allow continuous monitoring of possible adverse effects (predictable Or unexpected) health products. These protocols for therapeutic use are validated by the ANSM (the National Agency for the Safety of Medicines and Health Products).

The CEVIDRA Laboratory manages Temporary Cohort Usage Authorizations (ATUc) on a daily basis and in accordance with the dossiers validated by the National Agency for the Safety of Medicines and Health Products (ANSM) since inclusion and follow-up of patients up to To the collection of data and the preparation of periodic synthesis reports.

 

 





MARKETING AUTHORIZATION (MA)

The CEVIDRA Laboratory ensures, in consultation with the manufacturer of the medicinal product, the processes of registering the medicinal product and obtaining reimbursement prices by participating in the preparation and submission of dossiers and in negotiations with the competent authorities.

The CEVIDRA Laboratory is responsible for the distribution and use of medicines with a marketing authorization (Marketing Authorization), which controls advertising and promotes medicinal products to specialists in accordance with the rules established by the Health Authorities.





PRODUCT WITH SPECIAL IMPORT AUTHORIZATION

Information from the Kela Pharma Laboratory on the DIPHANTOINE specialty in France.



















Laboratoire CEVIDRA map 45 Boulevard Marcel Pagnol 06130 Grasse - FRANCE tel +33 (0)4 93 70 58 31 mail contact@cevidra.com